To evaluate the effect of ARB on inflammation in rats with dyslipidemia, we measured liver NF-κB p65 that exhibited significant increase in hyperlipidemic rats (p < 0.001; Figure 7A). The gene discussed is NFKB1; the disease is metabolic syndrome.